FireFly Metals Ltd reported a reduced half-year loss of A$5.7 million for December 2024, bolstered by a significant increase in cash reserves and strategic asset acquisitions in Canada and Australia.
Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.
Copper Search Limited has entered an exclusive option and joint venture agreement to earn up to 75% in the Byrock Project, a highly prospective copper-gold exploration asset in the Lachlan Fold Belt, NSW. The company plans to commence drilling in Q3 2025, aiming to unlock significant shareholder value through large-scale discovery.
Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.
Ora Banda Mining reports a robust December quarter, boosting cash reserves to $57.8 million and advancing underground operations at Riverina and Sand King towards a 150koz production target in FY26.